1 citations
,
January 2015 in “Hair therapy & transplantation” The authors argue that despite the growing popularity of hair transplantation for aesthetic reasons, many patients often experience disappointment and frustration after multiple procedures.
1 citations
,
January 1997 in “Journal of Investigative Dermatology” In this study using a macaque model, RU58841 at a 5% concentration significantly increased hair density, thickness, and length in the frontal bald scalp over six months.
November 2025 in “Yemeni Journal For Medical Sciences” This study assessed contraceptive use among women in Mukalla city, Yemen, reporting that 78.7% experienced side effects such as hair loss and abnormal bleeding, with oral contraceptive pills being the most common method.
July 2025 in “Malaria Journal” This study suggests that while Nanostring profiling identifies important processes in resolving MA-ARDS, solely targeting late-stage resolution by altering SPM production is not enough. The researchers conclude that combining multi-targeted adjunctive therapies with antimalarial drugs may be necessary to enhance survival and recovery.
September 2024 in “Frontiers in Genetics” In this study, researchers found a significant association between the rs13405699 SNP at 2q31.1 and male pattern baldness among Han Chinese men, suggesting genetic influence on this condition in this population.
July 2023 in “International journal of life science and pharma research” In this study, a herbal hair cream containing extracts from Hibiscus rosa sinensis, Eclipta alba, and Solanum nigrum was developed, showing promising in-vitro inhibition of the 5α-reductase enzyme and potential benefits for alopecia treatment.
June 2023 in “International journal of pharmaceutical quality assurance” This study found that Eclipta alba extracts exhibit 5α-reductase inhibitory activity, with the methanolic extract showing a higher concentration of β-sitosterol compared to petroleum ether extract, indicating potential for treating androgenic conditions like male pattern baldness.
February 2023 in “Biological and Clinical Sciences Research Journal” This study found that patients undergoing chemotherapy frequently experienced skin manifestations, with alopecia, mucositis, and dry skin being the most common, irrespective of age or gender.
January 2023 in “Brazilian Journal of Pharmaceutical Sciences” This study concluded that the liquid chromatography-mass spectrometry method developed is viable for accurately quantifying spironolactone and its metabolite canrenone in plasma despite interference from plasma components.
July 2026 in “bioRxiv (Cold Spring Harbor Laboratory)” This study identified a new FAK isoform, FAKΔe4, which is regulated by ECM stiffness and affects cell migration, invasion, and mechanosensing in human-derived data and engineered models.
July 2026 in “Journal of Cutaneous and Aesthetic Surgery” In this study, researchers treated 20 patients with lip vitiligo using manual needling followed by 88% phenol application and found that 65% of patients achieved more than 75% repigmentation within three months, indicating this combination as an effective treatment option.
This systematic review found that topical minoxidil significantly increases nail growth in healthy individuals and patients with nail disorders, showing a promising mean increase in growth rate and clinical response compared to controls, without serious adverse effects reported.
This systematic review found that topical minoxidil may safely enhance nail growth, with significant increases observed in healthy individuals and those with nail disorders, although larger trials are necessary to confirm its long-term efficacy.
This study reports the development of a natural hair-coloring system using size-controlled ink particles from cuttlefish ink combined with chitosan, achieving darker and more uniform black coloration on hair than existing plant-based natural colorants, without the need for metallic mordants.
April 2026 in “microPublication” In this study, researchers explored whether minoxidil, a common treatment for androgenetic alopecia, may have estrogenic activity and found preliminary evidence suggesting it could act as a partial agonist of Estrogen Receptor α (ERα).
This study developed consensus guidelines for the use of low-dose oral and topical minoxidil in male and female pattern hair loss, recommending specific doses, monitoring procedures, and timing of application around hair transplant surgeries.
This study developed expert consensus guidelines on using low-dose oral and topical minoxidil for pattern hair loss around hair transplant surgery, recommending specific doses, monitoring practices, and timing of use for both male and female patients.
This study developed consensus guidelines for using low-dose oral and topical minoxidil in patients undergoing hair transplant surgery for pattern hair loss, recommending dosing adjustments, monitoring protocols, and timing for post-surgery application.
February 2026 in “Expert Opinion on Pharmacotherapy” This study established consensus-based guidelines for using low-dose oral and topical minoxidil in managing pattern hair loss for patients undergoing hair transplant surgery, recommending specific dosages, monitoring procedures, and timing for initiation post-surgery.
January 2026 in “EJC Skin Cancer” This research underscores the significant challenge of managing hair loss after cancer treatment and explores the need to evaluate new topical strategies to promote faster and higher-quality hair regrowth, as existing recovery processes are often slow and sometimes incomplete.
December 2025 in “International Journal of Research in Dermatology” In this survey, dermatologists in India reported preferring alcohol-free minoxidil combined with procapil and finasteride over traditional alcohol-based formulations for managing androgenetic alopecia, citing better tolerance and patient adherence.
December 2025 in “Zona Kebidanan Program Studi Kebidanan Universitas Batam” In this study, postpartum mothers using bitter melon fruit masks reported a significant reduction in hair loss, with 26 out of 30 participants experiencing improvements, as analyzed by the Wilcoxon test (p < 0.001).
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that many women aged 40 to 65 in urban Bangalore have magnesium intake below recommended levels, with symptoms like hair loss and muscle cramps being widespread.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers assessed magnesium intake in women aged 40 to 65 across urban Bangalore, finding it below the Recommended Dietary Allowance and noting deficiencies associated with symptoms like hair loss and muscle cramps. Biochemical assessment was recommended to confirm these findings.
November 2025 in “PubMed” This study identified nine pathogenic variants in the PADI3 gene, and variants in the S100A3 and TCHH genes, which may disrupt protein function and contribute to central centrifugal cicatricial alopecia.
September 2025 in “Mansoura Journal of Chemistry” This study found that certain blood and urine markers, such as reduced hemoglobin and leukocyte counts and elevated proteinuria, are significant in diagnosing juvenile systemic lupus erythematosus, underscoring the need for further research to refine diagnostic criteria and improve patient outcomes.
May 2025 in “Australasian Journal of Dermatology” In this observational study, researchers reported a significant association between COVID-19 infection or vaccination and the development of new-onset lichen planus, suggesting these events, particularly infection, may act as triggers for the condition.
March 2025 in “Journal of Cutaneous Medicine and Surgery” In this study, researchers found that 48.59% of dermatologists in Ontario do not accept OHIP referrals for hair loss, with average wait times of about 4.5 months for those who do; this raises accessibility concerns.
January 2025 in “Indian Journal of Small Ruminants (The)” In this case study of a Beetal doe with severe skin lesions, the researchers diagnosed concurrent psoroptic mange and malasseziosis, and reported successful treatment with a combination of Ivermectin, antibiotics, and topical applications, leading to reduced skin lesions and new hair growth.
In this study, xerosis and pruritus were common skin issues in pediatric chronic kidney disease patients, with xerosis linked to lower hemodialysis efficacy and higher white blood cells, and pruritis associated with higher hemoglobin levels.